Systematic review: gene expression profiling assays in early-stage breast cancer.
about
Comparison of EndoPredict and Oncotype DX test results in hormone receptor positive invasive breast cancerComputational medicine: translating models to clinical careHow do women trade-off benefits and risks in chemotherapy treatment decisions based on gene expression profiling for early-stage breast cancer? A discrete choice experimentThe impact of the Oncotype Dx breast cancer assay in clinical practice: a systematic review and meta-analysisNavigating the rapids: the development of regulated next-generation sequencing-based clinical trial assays and companion diagnosticsGenomics, personalized medicine, and pediatricsMolecular portraits: the evolution of the concept of transcriptome-based cancer signaturesA 20-gene model for molecular nodal staging of bladder cancer: development and prospective assessment.Systematic analysis of challenge-driven improvements in molecular prognostic models for breast cancerThe ordering of expression among a few genes can provide simple cancer biomarkers and signal BRCA1 mutations.Gene expression profiling of breast cancer.Predicting prognosis of breast cancer with gene signatures: are we lost in a sea of data?Optimizing the Use of Gene Expression Profiling in Early-Stage Breast Cancer.Traditional statistical methods for evaluating prediction models are uninformative as to clinical value: towards a decision analytic framework.Cost-effectiveness analysis of recurrence score-guided treatment using a 21-gene assay in early breast cancerAssessment of Urokinase-Type Plasminogen Activator and Its Inhibitor PAI-1 in Breast Cancer Tissue: Historical Aspects and Future ProspectsCoverage policy development for personalized medicine: private payer perspectives on developing policy for the 21-gene assay.Utility of oncotype DX risk estimates in clinically intermediate risk hormone receptor-positive, HER2-normal, grade II, lymph node-negative breast cancers.GRP78 as potential predictor for breast cancer response to adjuvant taxane therapy.Molecular profiling contributes more than routine histology and immonohistochemistry to breast cancer diagnosticsA simple and reproducible breast cancer prognostic test.Understanding patient and provider perceptions and expectations of genomic medicine.Prognostic and Predictive Markers for Treatment Decisions in Early Breast CancerReview of the clinical studies using the 21-gene assay.Early developments in gene-expression profiling of breast tumors: potential for increasing black-white patient disparities in breast cancer outcomes?Prognostic classification of pediatric medulloblastoma based on chromosome 17p loss, expression of MYCC and MYCN, and Wnt pathway activation.Genome-wide methylation analysis identifies genes specific to breast cancer hormone receptor status and risk of recurrence.Estrogen-Receptor, Progesterone-Receptor and HER2 Status Determination in Invasive Breast Cancer. Concordance between Immuno-Histochemistry and MapQuant™ Microarray Based Assay.Trastuzumab for small HER-2+ breast cancer: small tumor, big decisionGene expression profiling for guiding adjuvant chemotherapy decisions in women with early breast cancer: an evidence-based and economic analysis.Barriers to the use of personalized medicine in breast cancer.Transcriptomic biomarkers for individual risk assessment in new-onset heart failure.An argument for mechanism-based statistical inference in cancer.Fluorescent polymer-based post-translational differentiation and subtyping of breast cancer cellsThe value of multigene predictors of clinical outcome in breast cancer: an analysis of the evidenceGene expression profile testing for breast cancer and the use of chemotherapy, serious adverse effects, and costs of careDecision analysis for the evaluation of diagnostic tests, prediction models and molecular markers.Chromatin Regulators as a Guide for Cancer Treatment ChoiceSerum protein profiling using an aptamer array predicts clinical outcomes of stage IIA colon cancer: A leave-one-out crossvalidation.Bringing diagnostic technologies to the clinical laboratory: Rigor, regulation, and reality
P2860
Q21089802-40C5B262-9432-4F38-9A6D-FF382553374AQ24594842-0F8A4E42-CEB3-44D4-B699-50C0934D2D2CQ24658523-F22D54A4-6214-417B-8490-E4984FAE0CC2Q26861418-4E0E6C09-D8A4-4534-94C3-C2B5EAE15B30Q26864332-33D93072-758C-4081-97CC-6F9DC2CA9090Q26991570-B455D402-9393-498B-B864-D971A9684215Q28607220-9ADF6683-3DB4-4BC5-A2B1-5E313F3E16ACQ30421675-38E64A61-4B0F-4AFB-8F21-DC3EFC4D94FCQ30566197-A831D7CB-E1EB-473A-8230-51B3CCD39BC3Q33495401-D41F79F8-7A7A-47C8-B7D9-977862902BC6Q33555497-2F13FD10-C054-4DF2-92BC-7938804FF521Q33751916-D4BD8FD9-8251-4E85-8309-E6818470CFF3Q33756398-E05ADE28-DE38-447A-9C14-7118D387F8FDQ33800997-A7A3A893-084F-4F88-8014-B9042243E828Q34022200-17221CF7-B3CF-4058-9440-12C4DB80C629Q34095769-0AB25941-5D00-4466-8766-F435DDCC911CQ34114888-A1D83C40-968F-4553-9C7B-A2DDF9073CFBQ34128373-04B32C66-6EF4-4D7E-BBD0-31FD466C3A39Q34274152-0CF3429B-74DA-48B9-B651-78BDB3F76868Q34423475-951AEBFB-8D0A-4F8B-A516-98FC9C983EA4Q34727251-9D5277A9-ADD0-4977-AC7B-FB6EB70E400DQ34859653-5E15735D-EB26-4BCD-838F-6DB4AA2EC84CQ35095603-53F99F72-7B10-4DA0-BD45-BF68C0B9CF23Q35584053-891DCB3E-9FDC-447D-A548-80CD93E26A66Q35622059-403BC9A8-D0AF-4ED4-8CB5-C73FF498DECCQ35696363-34760D61-AC0F-4701-9872-6BB9E4774895Q35841605-68990A25-C0FA-4F20-B9D2-AB4BCD333D68Q35909719-5DED8EFC-672E-41E3-9DBB-B5B81F4B0DD5Q35913229-76D52EF5-54E2-4E52-A374-FB2F51AA9B98Q36055953-3D71B688-1110-4918-AE28-13DD6B9798DCQ36095254-4523BEBB-C94E-4467-8E7A-6691A6DF1A69Q36126734-86C729B1-242A-4033-B542-53F22DFF6657Q36182146-665A3BFB-457B-4ABE-8897-FAD4E47308EFQ36376254-90E2972B-51FD-4190-B4B8-2DFBFC252F39Q36462893-CD11E26A-1AEC-4096-8AAE-C66A600ED56FQ36661690-471783DD-0CB6-4942-B88B-79F90F6D964FQ37039297-142CAB47-808C-4579-A33F-7F229C5C1CFAQ37075234-E81C0F29-60ED-4B2F-BD2F-FF4479CBDDA1Q37086027-EC1A6120-C40A-45B2-B78C-F5D5474D24A8Q37140372-FBEB2B1B-8894-4CF9-AF77-AE5D9C25D5B7
P2860
Systematic review: gene expression profiling assays in early-stage breast cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 04 February 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Systematic review: gene expression profiling assays in early-stage breast cancer.
@en
Systematic review: gene expression profiling assays in early-stage breast cancer.
@nl
type
label
Systematic review: gene expression profiling assays in early-stage breast cancer.
@en
Systematic review: gene expression profiling assays in early-stage breast cancer.
@nl
prefLabel
Systematic review: gene expression profiling assays in early-stage breast cancer.
@en
Systematic review: gene expression profiling assays in early-stage breast cancer.
@nl
P2093
P1476
Systematic review: gene expression profiling assays in early-stage breast cancer.
@en
P2093
Antonio C Wolff
Eric B Bass
Giovanni Parmigiani
Luigi Marchionni
Renee F Wilson
Spyridon Marinopoulos
Steven N Goodman
P304
P356
10.7326/0003-4819-148-5-200803040-00208
P407
P577
2008-02-04T00:00:00Z